Sort
130,381 grants matching “hiv”
(HVTN) HIV VACCINE TRIAL UNITS
$2,267,098Johns Hopkins University · U01 · FY2000 · AI
Malaria immunology
$2,266,523Susan Pierce · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Biodefense/Emerging Infection Vaccine Studies
$2,265,989Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY
$2,265,914Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2017 · AI
Maximizing CD8 T Cells for Protection
$2,265,000David Masopust · University Of Minnesota · DP2 · FY2009 · OD
Vaccination against mucosal HIV clade C transmission
$2,264,811Ruth Margrit Ruprecht · Dana-Farber Cancer Inst · P01 · FY2008 · AI
PATHOGENESIS AND TREATMENT OF ACUTE HIV INFECTION
$2,264,709Massachusetts General Hospital · U01 · FY2004 · AI
The Johns Hopkins University - Uganda Clinical Trials Unit
$2,263,627Mary Glenn Fowler · Johns Hopkins University · UM1 · FY2023 · AI
Maternal and infant immunization to eliminate breast milk transmission of HIV-1
$2,263,268Sallie R. Permar · Duke University · P01 · FY2017 · AI
HIV Neurobehavioral Research Center
$2,261,800Igor Grant · University Of California, San Diego · P30 · FY2007 · MH
SPORE in Cervical Cancer
$2,261,467T.-C. Wu · Johns Hopkins University · P50 · FY2025 · CA
Spatio-temporal Methods for Surveillance of the Opioid Syndemic
$2,260,761David M Kline · Wake Forest University Health Sciences · R01 · FY2025 · DA
PONCE SCHOOL OF MEDICINE RCMI PROGRAM
$2,260,611Raul A Armstrong · Ponce School Of Medicine · G12 · FY2006 · RR
NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LAB AIDS VACCINE R&D
$2,260,130David C Montefiori · Duke University · N01 · FY2015 · AI
Preclinical Evaluation of Advanced Pan-Lassa Immunotherapeutic Cocktails
$2,258,151Robert F Garry · La Jolla Institute For Immunology · U19 · FY2020 · AI
The MobileToolbox for Monitoring Cognitive Function
$2,257,621Richard Gershon · Northwestern University At Chicago · U2C · FY2021 · AG
Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs
$2,257,200Billy Scott · Population Services International · U2G · FY2013 · GH
The Southwest National Primate Research Center: Rhesus Macaque Expansion
$2,256,688Larry S. Schlesinger · Texas Biomedical Research Institute · P51 · FY2022 · OD
University of Pittsburgh Clinical Trials Unit
$2,256,665John W Mellors · University Of Pittsburgh At Pittsburgh · U01 · FY2008 · AI
Novel SIVsmm strains for analysis of mucosal transmission and vaccine protection
$2,256,286George M Shaw · University Of Alabama At Birmingham · P01 · FY2010 · AI
RNA-based HIV-1 chimera vaccines encoding a trimerizing host self-protein protomer linked to a viral MPER-TM segment
$2,256,224Ellis L Reinherz · Dana-Farber Cancer Inst · P01 · FY2025 · AI
Anti-HIV Gene Therapy: Defend and Attack
$2,256,106Irvin S.y. Chen · University Of California Los Angeles · U19 · FY2015 · AI
Griffithsin-based Rectal Microbicides for PREvention of Viral ENTry (PREVENT)
$2,255,692Kenneth E Palmer · University Of Louisville · U19 · FY2017 · AI
DISSECTING MECHANISMS OF INFLAMMATORY SIGNALING ACROSS THE MATERNAL FETAL INTERFACE
$2,255,352Christiana Elizabeth Smith-Anderson · University Of Colorado Denver · R01 · FY2025 · HD
Increasing Access to Hepatitis C Treatment in Opioid Endemic Rural Areas: the Kentucky Viral Hepatitis Treatment (KeY Treat) Study
$2,255,132Jennifer R Havens · University Of Kentucky · R01 · FY2019 · DA